Verona Pharma plc Net Asset Quality Index
Verona Pharma plc net asset quality index. Verona Pharma plc (I9SA) has a Net Asset Quality Index of 48.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €572.87 Million minus total liabilities of €294.60 Million yields net assets of €278.27 Million. A higher index indicates a stronger, lower-leverage balance sheet. See I9SA net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Verona Pharma plc (2016–2024)
Net asset quality index of Verona Pharma plc from 2016 to 2024. This chart shows how Verona Pharma plc's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 48.6%, representing net assets of €278.27 Million against total assets of €572.87 Million EUR. Check Verona Pharma plc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Verona Pharma plc Net Asset Quality Index by Year (2016–2024)
Verona Pharma plc net asset quality index by year from 2016 to 2024. The table below presents the year-by-year Net Asset Quality Index for Verona Pharma plc from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see I9SA stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 43.1% | €204.56 Million | €474.24 Million | €269.68 Million | ▼ -37.8 pp |
| 2023 | 80.9% | €249.28 Million | €308.12 Million | €58.84 Million | ▼ -7.9 pp |
| 2022 | 88.8% | €230.47 Million | €259.47 Million | €29.00 Million | ▲ +9.5 pp |
| 2021 | 79.3% | €148.00 Million | €186.59 Million | €38.58 Million | ▼ -11.2 pp |
| 2020 | 90.5% | €184.85 Million | €204.21 Million | €19.35 Million | ▲ +15.5 pp |
| 2019 | 75.0% | €44.40 Million | €59.18 Million | €14.78 Million | ▼ -9.7 pp |
| 2018 | 84.7% | €79.86 Million | €94.23 Million | €14.37 Million | ▼ -4.5 pp |
| 2017 | 89.2% | €107.95 Million | €120.96 Million | €13.00 Million | ▲ +14.5 pp |
| 2016 | 74.7% | €42.53 Million | €56.93 Million | €14.40 Million | — |